Centre for Biomaterials, Cellular and Molecular Theranostics (CBCMT)
Patient specific 3D / 4D Printing for Disease Diagnosis and Tissue Replacement.
Centre for Bio Materials, Cellular and Molecular Theranostics (CBCMT) was established in the year 2013 under the able leadership of Prof. Geetha Manivasagam is an integral part of VIT. This interdisciplinary research center works on cutting edge science at the interface of physical, biological, chemical and engineering sciences. The research team comprise of material scientists, metallurgists, physicists, electrical engineers, bioengineers, chemists, biologists and clinicians, who work together to address the unmet needs in the areas of biomaterials, cellular and molecular theranostics. Some of the key focus areas include bone tissue engineering, biocorrosion and biomechanics, cardiac tissue engineering, corneal tissue regeneration, drug discovery and delivery, quantum dots for theranostics, sensors for microbial detection and implant health monitoring, stem cell delivery.
CBCMT is equipped with high-end instruments to carry out experiments ranging from materials synthesis, material processing, characterizations as well as advanced tissue culture facilities. The recent addition to this center, HOME (Human Organ Manufacturing and Engineering) Lab is an advanced 3D bioprinting facility equipped with two high-end Cellink BioX bioprinter, few basic bioprinters, and a high-end Confocal Laser Scanning Microscopy Facility. With this addition, centre is better positioned to fabricate 3D organoids, tissue mimics, which will also be one of the key focus areas in coming years.The ongoing projects of the center are funded by both national and international funding agencies. The center also has a strong research collaboration with scientists from leading research laboratories within India as well as across the globe.
CBCMT thrives to be the hub of translational research in order to address the unmet needs in treating several critical disorders through cutting edge technologies
To provide state-of-the-art health-care options for patients by developing efficient, cost-effective and safe treatment strategies through multidisciplinary research
- Quality - Excellent research with translational impact
- Growth - Innovation, continued development and improved performance
- Integrity - Maintaining highest standard of ethics in research
- Accountability - Social and scientific responsibility